BB
BB Biotech Portfolio holdings
AUM
$3.98B
1-Year Return
15.06%
This Quarter Return
+15.39%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.55B
AUM Growth
+$396M
(+13%)
Cap. Flow
+$39.7M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
73.18%
Holding
30
New
2
Increased
6
Reduced
5
Closed
–
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$41.3M |
| 2 |
Cidara Therapeutics
CDTX
|
$8.01M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$6.72M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$3.92M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$3.25M |
Top Sells
| 1 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$11.2M |
| 2 |
Puma Biotechnology
PBYI
|
$7.06M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$6.5M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$3.15M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.83M |
Sector Composition
| 1 | Healthcare | 86.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Esperion Therapeutics
ESPR
$494M
| $20.2M | 0.57% |
908,542
| – | – |
|
|
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
| $18.5M | 0.52% |
528,188
-90,000
| -15% | -$3.15M |
|
|
ACHN
28
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $13.8M | 0.39% |
1,279,340
| – | – |
|
|
29
Cidara Therapeutics
CDTX
$1.61B
| $8.01M | 0.23% |
+23,334
| New | +$8.01M |
|
|
TTPH
30
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.67M | 0.1% |
18,310
-55,796
| -75% | -$11.2M |
|